Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma

Background Neoadjuvant therapy (NAT) is a useful therapeutic option. However, some patients respond poorly to it and can even show tumor progression. It is important to define factors that can predict response to NAT.